Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
2008 StandoutScienceNobel
Characterization of Chemokines and Adhesion Molecules Associated with T cell Presence in Tertiary Lymphoid Structures in Human Lung Cancer
2011
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Feedback control of regulatory T cell homeostasis by dendritic cells in vivo
2009
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
B cell depletion reduces the development of atherosclerosis in mice
2010
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 StandoutScienceNobel
CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets
2013
Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization
2005 StandoutNobel
Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease
2007
Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
2013 StandoutNobel
Eos Mediates Foxp3-Dependent Gene Silencing in CD4 + Regulatory T Cells
2009 Science
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
2004
Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo
2005
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Effective expansion of alloantigen-specific Foxp3 + CD25 + CD4 + regulatory T cells by dendritic cells during the mixed leukocyte reaction
2006 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Regulatory T Cells Dynamically Control the Primary Immune Response to Foreign Antigen
2007
CTLA-4 Controls Regulatory T Cell Peripheral Homeostasis and Is Required for Suppression of Pancreatic Islet Autoimmunity
2009
The Initial Phase of an Immune Response Functions to Activate Regulatory T Cells
2009
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Recognition of the Peripheral Self by Naturally Arising CD25+ CD4+ T Cell Receptors
2004
The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology
2006
Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis
2011 StandoutNobel
Foxp3 Transcription-Factor-Dependent and -Independent Regulation of the Regulatory T Cell Transcriptional Signature
2007
CD4 + T Cell Tolerance to Tissue-Restricted Self Antigens Is Mediated by Antigen-Specific Regulatory T Cells Rather Than Deletion
2015
Homing to suppress: address codes for Treg migration
2005
Suppressive properties of human CD4+CD25+ regulatory T cells are dependent on CTLA‐4 expression
2004
Continuous requirement for the TCR in regulatory T cell function
2014
Trial Watch: Monoclonal antibodies in cancer therapy
2012
Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function
2004
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
2015
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
2013
Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice
2013
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
2011 StandoutNobel
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics
2013
12-Chemokine Gene Signature Identifies Lymph Node-like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?
2012
Control of Immune Responses by Antigen-Specific Regulatory T Cells Expressing the Folate Receptor
2007 StandoutNobel
Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
2005 StandoutNobel
Evolving synergistic combinations of targeted immunotherapies to combat cancer
2015
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
2006 StandoutNobel
Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice
2019
The immune system in atherosclerosis
2011 Standout
Immune infiltration in human tumors: a prognostic factor that should not be ignored
2009
Regulatory T cells
2004
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
An obligate cell-intrinsic function for CD28 in Tregs
2013
Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?
2007
Adaptive immunity and atherosclerosis
2009
Taking dendritic cells into medicine
2007 StandoutNatureNobel
The immune response in atherosclerosis: a double-edged sword
2006 Standout
Regulatory T cells in cancer immunotherapy
2016 StandoutNobel
Induction of FOXP3‐expressing regulatory CD4pos T cells by human mature autologous dendritic cells
2004
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
2007
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions
2009
Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo
2006
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells
2004 StandoutNobel
An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires
2006
Mechanisms of suppression by suppressor T cells
2005
Deacetylase inhibition promotes the generation and function of regulatory T cells
2007
Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion
2009 StandoutNobel
T Cells at the Site of Autoimmune Inflammation Show Increased Potential for Trogocytosis
2013
Regulatory T cells in nonlymphoid tissues
2013
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Detection of self-reactive CD8 + T cells with an anergic phenotype in healthy individuals
2014 StandoutScienceNobel
Role of Naturally Occurring CD4 + CD25 + Regulatory T Cells in Experimental Atherosclerosis
2007
Dendritic cells with TGF-β1 differentiate naïve CD4+CD25−T cells into islet-protective Foxp3+regulatory T cells
2007 StandoutNobel
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans
2015 StandoutNobel
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Regulatory T Cells and Human Disease
2020 StandoutNobel
Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses
2005
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
CD4+CD25+ T Regulatory Cells Dependent on ICOS Promote Regulation of Effector Cells in the Prediabetic Lesion
2004
Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells
2014
The Discovery of Cellular Immunity in the Atherosclerotic Plaque
2009
A role for Dicer in immune regulation
2006 StandoutNobel
Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
2004
Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node
2005
Interleukin-17: friend or foe in atherosclerosis?
2010
Natural Recovery and Protection from Autoimmune Encephalomyelitis: Contribution of CD4+CD25+ Regulatory Cells within the Central Nervous System
2005
In Vivo Instruction of Suppressor Commitment in Naive T Cells
2004
CD4+regulatory cells as a potential immunotherapy
2005 StandoutNobel
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Foxp3+natural regulatory T cells preferentially form aggregates on dendritic cellsin vitroand actively inhibit their maturation
2008 StandoutNobel
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
2005
Emerging Challenges in Regulatory T Cell Function and Biology
2007 StandoutScienceNobel
Conventional Dendritic Cells at the Crossroads Between Immunity and Cholesterol Homeostasis in Atherosclerosis
2009
Dendritic cells expand antigen‐specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity
2006 StandoutNobel
Conditional stability of T cells
2010 StandoutNatureNobel
Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells
2004
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
CTLA-4–mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells
2019
Natural regulatory T cells: mechanisms of suppression
2007 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune Diabetes
2004 StandoutNobel
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice
2009
Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes
2004
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
2010
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
2009
Antigen-specific peripheral shaping of the natural regulatory T cell population
2008
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Oral Administration of an Active Form of Vitamin D 3 (Calcitriol) Decreases Atherosclerosis in Mice by Inducing Regulatory T Cells and Immature Dendritic Cells With Tolerogenic Functions
2010
In vitro–expanded human CD4+CD25+ T-regulatory cells can markedly inhibit allogeneic dendritic cell–stimulated MLR cultures
2004
Works of Sylvain Fisson being referenced
Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis
2007
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia
2003
Immune Infiltration in Human Cancer: Prognostic Significance and Disease Control
2010
Tumor microenvironment is multifaceted
2011
Selective expression of inhibitory Fcγ receptor by metastatic melanoma impairs tumor susceptibility to IgG‐dependent cellular response
2008
Natural regulatory T cells control the development of atherosclerosis in mice
2006
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia
2003
Impaired Th1/Tc1 Cytokine Production of Tumor-Infiltrating Lymphocytes in a Model of Primary Intraocular B-Cell Lymphoma
2007
Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State
2003